Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 265 Records) |
Query Trace: Lymphoma and EGFR[original query] |
---|
Advances in the treatment of postoperative recurrence of non-small cell lung cancer and their impact on survival in Asian patients. The Journal of thoracic and cardiovascular surgery 2022 Aug . Hashimoto Kohei, Ariyasu Ryo, Ichinose Junji, Matsuura Yosuke, Nakao Masayuki, Amino Yoshiaki, Uchibori Ken, Kitazono Satoru, Yanagitani Noriko, Okumura Sakae, Nishio Makoto, Mun Mingy |
Open-label, multi-center, phase II study of adjuvant pemetrexed plus cisplatin for completely resected stage IB to IIIA adenocarcinoma of the lung: APICAL trial. Translational lung cancer research 2022 9 11 (8): 1606-1618. Park Cheol-Kyu, Oh Hyung-Joo, Yoo Seung Soo, Lee Shin Yup, Lee Sang Hoon, Kim Eun Young, Lee Sung Yong, Choi Juwhan, Lee Min Ki, Kim Mi-Hyun, Jang Tae Won, Chung Chaeuk, Oh In-Jae, Kim Young-Ch |
Differentiating EGFR from ALK mutation status using radiomics signature based on MR sequences of brain metastasis. European journal of radiology 2022 Oct 155 110499. Li Ye, Lv Xinna, Wang Bing, Xu Zexuan, Wang Yichuan, Gao Shan, Hou Dail |
Treatment pattern and outcomes in de novo T790M-mutated non-small cell lung cancer. Ecancermedicalscience 2022 8 16 1385. Panda Goutam Santosh, Noronha Vanita, Shah Darshit, John George, Chougule Anuradha, Patil Vijay, Kumar Rajiv, Menon Nandini, Singh Ajay, Chandrani Pratik, Mahajan Abhishek, Prabhash Kum |
Targeted Therapies and Utility of the Lung-molGPA in Non-Small-Cell Lung Cancer Patients with Brain Metastases. Oncology 2022 8 100 (10): 542-554. Cacho-Díaz Bernardo, Cuapantécatl Laura D, Garcilazo-Reyes Ytel J, Cabrera-Miranda Luis, Hernandez-Martinez Juan-Manuel, Arrieta Osc |
Five-Year Overall Survival and Prognostic Factors in Patients with Lung Cancer: Results from the Korean Association of Lung Cancer Registry (KALC-R) 2015. Cancer research and treatment 2022 7 55 (1): 103-111. Jeon Da Som, Kim Ho Cheol, Kim Se Hee, Kim Tae-Jung, Kim Hong Kwan, Moon Mi Hyung, Beck Kyongmin Sarah, Suh Yang-Gun, Song Changhoon, Ahn Jin Seok, Lee Jeong Eun, Lim Jeong Uk, Jeon Jae Hyun, Jung Kyu-Won, Jung Chi Young, Cho Jeong Su, Choi Yoo-Duk, Hwang Seung-Sik, Choi Chang-Min, , |
CKAP2 overexpression correlates with worse overall survival in patients with lung adenocarcinoma. Medicine 2022 Jul 101 (30): e29796. Zhang Sen, Li Na, Yang Yonghua, Li Yan, Lin Chenshi, Fu Guoquan, Cai J |
Genotyping of cerebrospinal fluid in lung cancer patients with leptomeningeal metastasis. Thoracic cancer 2022 Sep 13 (18): 2574-2583. Nie Naifu, Zhou Haodong, Zhang Kejun, Liu Lan, Luo Nuo, Wang Renyuan, Li Xin, Zhu Mengxiao, Hu Chen, Wang Yubo, Liu Zhulin, Li Li, He Yo |
Computed tomography-guided lung biopsy for molecular tests: a meta-analysis. Kardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery 2022 Jun 19 (2): 96-101. Zhang Jian-Hua, Xia Feng-Fei, Yang Xiao-Shan, Li |
PD-1 inhibitors plus chemotherapy in EGFR/ALK-positive NSCLC patients with brain metastases and disease progression after EGFR/ALK-TKIs therapy. Journal of cancer research and clinical oncology 2022 7 148 (12): 3557-3566. Zhu Yixiang, Zhang Ye, Hu Xingsheng, Wang Mingzhao, Wang Hongyu, Liu Yut |
The prognostic role of PD-1, PD-L1, ALK, and ROS1 proteins expression in non-small cell lung carcinoma patients from Egypt. Journal of the Egyptian National Cancer Institute 2022 6 34 (1): 23. Bahnassy Abeer A, Ismail Hoda, Mohanad Marwa, El-Bastawisy Ahmed, Yousef Hend |
A Somatic Mutation Signature Predicts the Best Overall Response to Anti-programmed Cell Death Protein-1 Treatment in Epidermal Growth Factor Receptor/Anaplastic Lymphoma Kinase-Negative Non-squamous Non-small Cell Lung Cancer. Frontiers in medicine 2022 9 808378. Peng Jie, Xiao Lushan, Zou Dan, Han Lij |
Development of Pericardial Effusion in Non-small Cell Lung Cancer Is Associated with the Presence of EGFR/ALK Mutations. The Israel Medical Association journal : IMAJ 2022 3 24 (3): 135-139. Nardi-Agmon Inbar, Zer Alona, Peysakhovich Yuri, Margalit Ili, Kornowski Ran, Peled Nir, Iakobishvili Za |
[Relationship between EGFR, ALK Gene Mutation and Imaging ?and Pathological Features in Invasive Lung Adenocarcinoma]. Zhongguo fei ai za zhi = Chinese journal of lung cancer 2022 3 25 (3): 147-155. Yang He, Liu Zicheng, Wang Hongya, Chen Liang, Wang Jun, Wen Wei, Xu Xinfeng, Zhu Qu |
Causal Association between Chronic Kidney Disease and Risk of 19 Site-Specific Cancers: A Mendelian Randomization Study. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2022 3 31 (6): 1233-1242. Tang Lei, Li Chunyang, Chen Wenwen, Zeng Yu, Yang Huazhen, Hu Yao, Song Huan, Zeng Xiaoxi, Li Qiu, Fu Pi |
Risk of thromboembolism in non-small-cell lung cancers patients with different oncogenic drivers, including ROS1, ALK, and EGFR mutations. ESMO open 2022 Dec 7 (6): 100742. Wang H-Y, Wu S-G, Lin Y-T, Chen C-Y, Shih J |
Actionable mutations in non-small cell lung cancer in patients at hospital de Especialidades Eugenio Espejo, Ecuador 2017-2020. Drug metabolism and personalized therapy 2022 12 . Fernández Freire Miguel Ángel, Gálvez Salazar Gabriela Isabel, Scudeler Mariana Meira, Rodrigues-Soares Fernanda, Jaramillo Koupermann Gabriela Fernanda, Moreno Ocampo Andrea Pao |
RT-based combination therapy for brain metastasis from NSCLC with non-EGFR mutation/ALK gene rearrangement: A network meta-analysis. Frontiers in oncology 2022 12 12 1024833. Wu Min, Jiang Jun, Zhang Xuewen, Chen Jie, Chang Qiaomei, Chen Ro |
Age does matter in adolescents and young adults vs. older adults with lung adenocarcinoma: A retrospective analysis comparing clinical characteristics and outcomes in response to systematic treatments. Oncology letters 2022 Oct 24 (4): 362. Zhou Lin, Li Huiwu, Yang Shuh |
Differential prognostic effect of systemic inflammation in patients with non-small cell lung cancer treated with immunotherapy or chemotherapy: A post hoc analysis of the phase 3 OAK trial. Cancer 2022 Jun . Cortellini Alessio, Ricciuti Biagio, Borghaei Hossein, Naqash Abdul Rafeh, D'Alessio Antonio, Fulgenzi Claudia A M, Addeo Alfredo, Banna Giuseppe L, Pinato David Jam |
Genomic profiling of primary diffuse large B-cell lymphoma of the central nervous system suggests novel potential therapeutic targets. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2023 9 100323. Claudio Agostinelli, Luca Morandi, Simona Righi, Luigi Cirillo, Marica Iommi, Caterina Tonon, Diego Mazzatenta, Matteo Zoli, Maura Rossi, Gianmarco Bagnato, Alessandro Broccoli, Raffaele Lodi, Pier Luigi Zinzani, Elena Sabattini, Caterina Giannini, Sofia Asio |
Deep learning based automated epidermal growth factor receptor and anaplastic lymphoma kinase status prediction of brain metastasis in non-small cell lung cancer. Exploration of targeted anti-tumor therapy 2023 9 4 (4): 657-668. Abhishek Mahajan, Gurukrishna B, Shweta Wadhwa, Ujjwal Agarwal, Ujjwal Baid, Sanjay Talbar, Amit Kumar Janu, Vijay Patil, Vanita Noronha, Naveen Mummudi, Anil Tibdewal, J P Agarwal, Subash Yadav, Rajiv Kumar Kaushal, Ameya Puranik, Nilendu Purandare, Kumar Prabha |
Investigation of EGFR and ALK mutation frequency and treatment results in advanced non-small cell lung cancer. Journal of cancer research and therapeutics 2023 5 19 (Supplement): S183-S190. Berna Komurcuoglu, Gamze Karakurt, Ozge O Kaya, Gulden Diniz, Ozgür K?rb?y?k, Aysen Evkan, Enver Yaln |
Association of PD-L1 expression with efficacy of alectinib in advanced NSCLC patients with ALK fusion. Lung cancer (Amsterdam, Netherlands) 2023 5 181 107233. Yingying Pan, Xinyu Liu, Wei Zhang, Wanying Wang, Haowei Wang, Libo Luo, Keyi Jia, Chuchu Shao, Shiqi Mao, Tianyu Qiu, Jun Ni, Jia Yu, Lei Wang, Bin Chen, Anwen Xiong, Guanghui Gao, Xiaoxia Chen, Fengying Wu, Caicun Zhou, Chunyan Wu, Shengxiang R |
Molecular patterns of egyptian patients with non-squamous non-small-cell lung cancers: a clinicopathological study. Journal of the Egyptian National Cancer Institute 2023 4 35 (1): 7. Ismail Mohamed Said, Kassem Loay, Ali Ahmed Al-Husseiny, Ahmed Fatma Elzahraa, Shalaby Mohamed, Magdy Sal |
Role of molecular testing for malignant pleural effusion in targeted therapy for advanced non-small cell lung cancer. Diagnostic cytopathology 2023 4 . Rixu Lin, Yida Li, Yi Lin, Wenyi Tian, Lei Jiang, Jianmin |
Adjuvant durvalumab after concurrent chemoradiotherapy for patients with unresectable stage III NSCLC harbouring uncommon genomic alterations. European journal of cancer (Oxford, England : 1990) 2023 3 184 172-178. Cortiula Francesco, De Ruysscher Dirk, Steens Michelle, Wijsman Robin, van der Wekken Anthonie, Alberti Martina, Hendriks Lizza E |
Genetic Alterations and Risk Factors for Recurrence in Patients with Non-Small Cell Lung Cancer Who Underwent Complete Surgical Resection. Cancers 2023 12 15 (23): . Hwa Kyung Park, Yoo Duk Choi, Ju-Sik Yun, Sang-Yun Song, Kook-Joo Na, Joon Young Yoon, Chang-Seok Yoon, Hyung-Joo Oh, Young-Chul Kim, In-Jae |
Synchronous Primary Lung Cancers Containing Discrete Driver Mutations in a Never-Smoker: Case Report. Case reports in oncology 2023 11 16 (1): 1384-1389. Andrew Davis, Sophia Jarrar, Christine Ciun |
Impacts of probiotics on the efficacies of immune checkpoint inhibitors with or without chemotherapy for patients with advanced non-small-cell lung cancer. International journal of cancer 2024 1 . Ayako Morita, Eiki Ichihara, Koji Inoue, Keiichi Fujiwara, Toshihide Yokoyama, Daijiro Harada, Chihiro Ando, Hirohisa Kano, Naohiro Oda, Tomoki Tamura, Nobuaki Ochi, Haruyuki Kawai, Masaaki Inoue, Naofumi Hara, Nobukazu Fujimoto, Hirohisa Ichikawa, Isao Oze, Katsuyuki Hotta, Yoshinobu Maeda, Katsuyuki Kiu |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 16, 2024
- Content source: